3-Hydroxy-3-Methylglutaric Aciduria
Oncology·MeSH: Jervell-Lange Nielsen Syndrome
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target 3-Hydroxy-3-Methylglutaric Aciduria?
There are 1 clinical trial targeting 3-Hydroxy-3-Methylglutaric Aciduria tracked by BioSniper.
What is the prevalence of 3-Hydroxy-3-Methylglutaric Aciduria?
The estimated prevalence of 3-Hydroxy-3-Methylglutaric Aciduria is approximately 0.5 per 100,000 population.
Deep-dive into 3-Hydroxy-3-Methylglutaric Aciduria
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis